Positive correlations (Fig. 8i) further support the likely pathogenic role of fibrotic processes in MS progression, while negative correlations support the beneficial role for remyelination-promoting RAR-, FXR/RXR pathways54,55. This evidence concerns the gene NR1H4 and myeloid sarcoma.